Publications

Filters: Keyword is Symposium I  [Clear All Filters]
Presentation
Laber, Eric B.. Adaptive inference after model selection., 2011.
Parmigiani, G. Adaptive randomized trial design for patients with recurrent glioblastom., 2011.
Wang, Xiaofei. Biased sampling and its applications in biomarker validation., 2011.
Korn, E. Biomarker-adaptive clinical trial designs., 2011.
Chen, Liddy M.. Design consideration for complex survival models., 2011.
Madigan, D. Drug safety in spontaneous reports, observational databases, and clinical trials: Can we do better?., 2011.
Zhao, Yingqi. Estimating Individualized Treatment Rules Using Outcome Weighted Learning., 2011.
Zeng, Donglin. Estimating treatment effects with treatment switching via semi-competing risks models: An application to a colorectal cancer study., 2011.
Li, Zhiguo. Fitting Cox models with doubly censored data using spline-based marginal likelihood., 2011.
Tzeng, Jung-Ying. A gene-trait similarity regression method for gene-level pharmacogenetics analysis., 2011.
Fine, Jason P.. An overview of competing risks data, with applications in clinical trials., 2011.
Auman, Todd. Pharmacogenomic interrogation of colorectal cancer using next-generation whole exome sequencing., 2011.
Davidian, Marie. A robust method for estimating optimal treatment regimes., 2011.
Levenson, M. Safety decision-making with multiple sources and different types of studies—recent examples from FDA Advisory Committees., 2011.
Hung, H M. James. Utilities and challenges of adaptive designs in drug development., 2011.